Melanoma of unknown origin: a case series.

Hdl Handle:
http://hdl.handle.net/10147/200019
Title:
Melanoma of unknown origin: a case series.
Authors:
Kelly, J; Redmond, H P
Affiliation:
Department of Academic Surgery, Cork University Hospital, Cork, Ireland. justinjoshkelly@gmail.com
Citation:
Melanoma of unknown origin: a case series. 2010, 179 (4):629-32 Ir J Med Sci
Journal:
Irish journal of medical science
Issue Date:
Dec-2010
URI:
http://hdl.handle.net/10147/200019
DOI:
10.1007/s11845-009-0405-6
PubMed ID:
19639362
Abstract:
The natural history of metastatic melanoma involving lymph nodes, in the absence of a known primary site (cutaneous, ocular or mucosal) has, to date, been poorly defined; and the optimal management of this rare subtype of disease is therefore unclear. Melanomas of unknown primary site (MUP) are estimated to comprise between 3.7 and 6% of all melanomas (Anbari et al. in Cancer 79:1861-1821, 1997).; Between 2002 and 2007, 478 patients were treated for melanoma in our department in Cork University Hospital, five of whom presented with MUP. We discuss their cases herein.; We should continue to treat this cohort of patients with an aggressive surgical approach and consider them for adjuvant therapies currently used to treat stage III disease.
Item Type:
Article
Language:
en
Description:
INTRODUCTION: The natural history of metastatic melanoma involving lymph nodes, in the absence of a known primary site (cutaneous, ocular or mucosal) has, to date, been poorly defined; and the optimal management of this rare subtype of disease is therefore unclear. Melanomas of unknown primary site (MUP) are estimated to comprise between 3.7 and 6% of all melanomas (Anbari et al. in Cancer 79:1861-1821, 1997). MATERIALS AND METHODS: Between 2002 and 2007, 478 patients were treated for melanoma in our department in Cork University Hospital, five of whom presented with MUP. We discuss their cases herein. CONCLUSION: We should continue to treat this cohort of patients with an aggressive surgical approach and consider them for adjuvant therapies currently used to treat stage III disease.
MeSH:
Adult; Humans; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography
ISSN:
1863-4362

Full metadata record

DC FieldValue Language
dc.contributor.authorKelly, Jen
dc.contributor.authorRedmond, H Pen
dc.date.accessioned2012-01-04T15:46:16Z-
dc.date.available2012-01-04T15:46:16Z-
dc.date.issued2010-12-
dc.identifier.citationMelanoma of unknown origin: a case series. 2010, 179 (4):629-32 Ir J Med Scien
dc.identifier.issn1863-4362-
dc.identifier.pmid19639362-
dc.identifier.doi10.1007/s11845-009-0405-6-
dc.identifier.urihttp://hdl.handle.net/10147/200019-
dc.descriptionINTRODUCTION: The natural history of metastatic melanoma involving lymph nodes, in the absence of a known primary site (cutaneous, ocular or mucosal) has, to date, been poorly defined; and the optimal management of this rare subtype of disease is therefore unclear. Melanomas of unknown primary site (MUP) are estimated to comprise between 3.7 and 6% of all melanomas (Anbari et al. in Cancer 79:1861-1821, 1997). MATERIALS AND METHODS: Between 2002 and 2007, 478 patients were treated for melanoma in our department in Cork University Hospital, five of whom presented with MUP. We discuss their cases herein. CONCLUSION: We should continue to treat this cohort of patients with an aggressive surgical approach and consider them for adjuvant therapies currently used to treat stage III disease.en
dc.description.abstractThe natural history of metastatic melanoma involving lymph nodes, in the absence of a known primary site (cutaneous, ocular or mucosal) has, to date, been poorly defined; and the optimal management of this rare subtype of disease is therefore unclear. Melanomas of unknown primary site (MUP) are estimated to comprise between 3.7 and 6% of all melanomas (Anbari et al. in Cancer 79:1861-1821, 1997).-
dc.description.abstractBetween 2002 and 2007, 478 patients were treated for melanoma in our department in Cork University Hospital, five of whom presented with MUP. We discuss their cases herein.-
dc.description.abstractWe should continue to treat this cohort of patients with an aggressive surgical approach and consider them for adjuvant therapies currently used to treat stage III disease.-
dc.language.isoenen
dc.subject.meshAdult-
dc.subject.meshHumans-
dc.subject.meshLymph Node Excision-
dc.subject.meshLymphatic Metastasis-
dc.subject.meshMelanoma-
dc.subject.meshMiddle Aged-
dc.subject.meshNeoplasms, Unknown Primary-
dc.subject.meshPositron-Emission Tomography-
dc.titleMelanoma of unknown origin: a case series.en
dc.typeArticleen
dc.contributor.departmentDepartment of Academic Surgery, Cork University Hospital, Cork, Ireland. justinjoshkelly@gmail.comen
dc.identifier.journalIrish journal of medical scienceen
dc.description.provinceMunster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.